A Comparative Study of Efficacy and Safety of Agomelatine and Escitalopram in Major Depressive Disorder
Background: Major depressive disorder (MDD) is a mental disorder characterized by episodes of depressed mood, loss of interest or pleasure, feeling of guilt or low self-esteem, loss of energy, altered sleep patterns and difficulty in concentration. Objective: This study was carried out to compare...
Main Authors: | Ravi Babu. Komaram, Srikrishna. Nukala, Jayasree. Palla, Lakshmana Rao. Nambaru, Satyanarayana Murthy. Kasturi |
---|---|
Format: | Article |
Language: | English |
Published: |
JCDR Research and Publications Private Limited
2015-06-01
|
Series: | Journal of Clinical and Diagnostic Research |
Subjects: | |
Online Access: | https://jcdr.net/articles/PDF/6092/12371_CE(RA1)_F(T)_PF1(PAK)_PFA(P)_PF2(PAG).pdf |
Similar Items
-
The Melatonergic System in Mood and Anxiety Disorders and the Role of Agomelatine: Implications for Clinical Practice
by: Domenico De Berardis, et al.
Published: (2013-06-01) -
Agomelatine beyond Borders: Current Evidences of Its Efficacy in Disorders Other than Major Depression
by: Domenico De Berardis, et al.
Published: (2015-01-01) -
Modulation of the Serotonergic Receptosome in the Treatment of Anxiety and Depression: A Narrative Review of the Experimental Evidence
by: Gustavo R. Villas-Boas, et al.
Published: (2021-02-01) -
Developmental Fluoxetine Exposure Alters Behavior and Neuropeptide Receptors in the Prairie Vole
by: Rebecca H. Lawrence, et al.
Published: (2020-11-01) -
Acute 5-HT2C Receptor Antagonist SB-242084 Treatment Affects EEG Gamma Band Activity Similarly to Chronic Escitalopram
by: Noémi Papp, et al.
Published: (2020-01-01)